Comparison of first-line (1L) treatment (tx) patterns and overall survival by age at diagnosis among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC).
| Publicado en: | Journal of Clinical Oncology Vol. 39; pp. 388 - 389 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
American Society of Clinical Oncology
2021 Supplement
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=183146568&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 183146568 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0732183X 20D jtl: Journal of Clinical Oncology issn: 0732183X maglogo: N pubinfo: dt: 2021 Supplement vid: 39 pid: 26892 pub: American Society of Clinical Oncology place: Alexandria, Virginia artinfo: ui: 183146568 10.1200/JCO.2021.39.3_suppl.388 183146568 ppf: 388 ppct: 1 formats: tig: atl: Comparison of first-line (1L) treatment (tx) patterns and overall survival by age at diagnosis among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC). aug: au: Elias, Rawad Cockrum, Paul Surinach, Andy Wang, Shu Chu, Bong Chul affil: Hartford Healthcare Cancer Institute, Hartford, CT sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|